Thomas McKee

9PUBLICATIONS
69CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 19, 2026
Survival of Colon Cancer in a Population-Based Cohort Study: A Comprehensive Analysis of Location of the Primary Tumor.

|Oct 16, 2024
Effectiveness of fractionated rituximab in preventing tumor lysis syndrome in aggressive B-cell lymphoma: Insights from real-life clinical practice.

Jasmine Mohamad, Antonin Bouroumeau, Thomas A McKee

|Jul 24, 2024
Targeting ferritinophagy impairs quiescent cancer stem cells in acute myeloid leukemia in vitro and in vivo models.

Clement Larrue, Sarah Mouche, Paolo Angelino

|Mar 21, 2024
High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency-Associated Genomic Instability in Ovarian Cancer.

Nicole Pfarr, Karin von Schwarzenberg, Dario Zocholl

|Aug 03, 2023
CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers.

Ruben Bill, Pratyaksha Wirapati, Marius Messemaker

|Jun 26, 2023
Normalized LST Is an Efficient Biomarker for Homologous Recombination Deficiency and Olaparib Response in Ovarian Carcinoma.

Yann Christinat, Liza Ho, Sophie Clément

Pageof 2

Frequent Collaborators

2 joint publications

Yann Christinat

1 joint publications

Valérie Dutoit

1 joint publications

Jimmy Stalin

1 joint publications

Beat A Imhof